Prime Medicine, Inc. (PRME)
NASDAQ: PRME · Real-Time Price · USD
1.460
0.00 (0.00%)
At close: Jun 13, 2025, 4:00 PM
1.520
+0.060 (4.11%)
After-hours: Jun 13, 2025, 7:56 PM EDT
Prime Medicine Market Cap
Prime Medicine has a market cap or net worth of $186.62 million as of June 13, 2025. Its market cap has decreased by -75.32% in one year.
Market Cap
186.62M
Enterprise Value
163.51M
1-Year Change
-75.32%
Ranking
Category
Stock Price
$1.46
Market Cap Chart
Since the IPO on October 20, 2022, Prime Medicine's market cap has decreased from $1.63B to $186.62M, a decrease of -88.53%. That is a compound annual growth rate of -55.84%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 13, 2025 | 186.62M | -49.91% |
| Dec 31, 2024 | 372.58M | -54.41% |
| Dec 29, 2023 | 817.15M | -49.22% |
| Dec 30, 2022 | 1.61B | -1.12% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 732.28B |
| Johnson & Johnson | 374.67B |
| Novo Nordisk | 353.20B |
| AbbVie | 339.87B |
| UnitedHealth Group | 281.20B |
| Abbott Laboratories | 235.16B |
| Novartis AG | 232.35B |
| AstraZeneca | 229.07B |